The goal of this clinical trial is to learn if intermittent or continuous enteral nutrition applications can improve glycemic control and affect certain metabolic parameters in adult critically ill patients with diabetes receiving clinical nutrition therapy. The main questions it aims to answer are: Does intermittent enteral nutrition lead to better glycemic control compared to continuous enteral nutrition? How do intermittent and continuous enteral nutrition applications affect metabolic parameters such as serum insulin levels, lipid profile, and inflammatory markers? Researchers will compare intermittent and continuous enteral nutrition groups to see if one method is more effective in improving glycemic control and metabolic outcomes. Participants will: Receive either intermittent or continuous enteral nutrition as part of their clinical nutrition therapy Have regular blood tests to monitor blood glucose, insulin, lipid profile, and inflammatory markers Be monitored for glycemic variability and metabolic changes during their ICU stay
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Blood Glucose Levels (mg/dL)
Timeframe: Five measurements per day at 06:00, 11:00, 16:00, 21:00, and 01:00, for 7 consecutive days